Today: 21 May 2026
Browse Category

NASDAQ:UREE 25 January 2026 - 18 May 2026

USA Rare Earth Drops After Rare-Earth Stocks Stall

USA Rare Earth Drops After Rare-Earth Stocks Stall

USA Rare Earth shares fell 12.8% to $21.28 Monday, trading nearly 18 million shares as investors pulled back from the volatile rare-earth sector. The drop followed news that defense firms are urging a delay to a ban on Chinese rare-earth magnets in U.S. military contracts. The company reported $5.7 million in first-quarter revenue and received a $14.18 million Texas grant for its Round Top Mountain project.
18 May 2026
··
USA Rare Earth stock whipsaws after Trump-backed $1.6 billion plan — what investors watch next

USA Rare Earth stock whipsaws after Trump-backed $1.6 billion plan — what investors watch next

USA Rare Earth shares rose about 8% to $26.72 in after-hours trading Monday after announcing a $277 million federal funding plan and $1.3 billion loan from the Commerce Department’s CHIPS Program. The company also secured $1.5 billion through a private investment in public equity. Trading volume reached 122 million shares. Reuters reported the Trump administration plans to acquire a 10% stake tied to a $1.6 billion deal.
26 January 2026
··

Stock Market Today

  • Teradyne, Kulicke and Soffa, Impinj, Microchip, IPG Photonics Stocks Slide on U.S.-China Semiconductor Summit Outcome
    May 21, 2026, 2:58 AM EDT. Shares of Teradyne, Kulicke and Soffa, Impinj, Microchip Technology, and IPG Photonics dropped sharply following the U.S.-China summit, which ended without key breakthroughs on semiconductor exports. Expectations for U.S. approval of Nvidia's H200 chip shipments to China were unmet, disappointing investors. U.S. Trade Representative Jamieson Greer indicated semiconductors were not a negotiation focus, dampening near-term optimism. Despite the sell-off, IPG Photonics' stock, known for volatility, remains down significantly from its 52-week high but has gained 34.3% year-to-date. Market reactions highlight cautious sentiment amid geopolitical tensions, with analysts skeptical about swift comprehensive deals due to national security concerns.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Go toTop